(Androisoxazol)
Neo-Ponden, also known as Androisoxazol, is a brand name for an orally active anabolic-androgenic steroid (AAS) that is a derivative of dihydrotestosterone (DHT), specifically the 17α-alkylated derivative. It’s known chemically as 17α-methyl-5α-androstano[3,2-c]isoxazol-17β-ol. Marketed in countries like Spain and Italy, Neo-Ponden is distinguished by two significant chemical alterations from DHT. First, it undergoes c-17alpha alkylation, a modification that protects it from degradation during its passage through the liver, allowing for oral administration. Second, it incorporates an isoxazole group, further differentiating it from its steroid precursor, DHT .
Dosage and administration
The advised dosage range for Neo-Poden users spans from 15-40 mg daily for a period of 6-8 weeks. This steroid, sharing low androgenicity characteristics akin to Winstrol and Anavar, is deemed appropriate for female use. For women, the dosage suggestion falls between 5-10 mg daily over a span of 4-6 weeks.
Regarding the intended uses and potential side effects of Neo-Poden, one might refer to the information provided for Winstrol.
Neo-Poden distinguishes itself as a versatile agent, compatible for combination with a wide array of substances, including other DHT derivatives. It is optimally employed within a cutting cycle framework, anchored by a testosterone base. This compound synergizes well with established cutting agents and versatile substances like Oxandrolone, Primobolan, Equipoise, Trenbolone, Oral Turinabol, and Stanozolol. Beyond its efficacy in cutting cycles, Neo-Poden also enhances bulking phases when paired with formidable anabolic agents such as testosterone, Deca-Durabolin, Equipoise, Trenbolone, Anadrol, and Halotestin, bolstering muscle development.
Health concerns
The health warnings for Neo-Poden (Androisoxazol), as with any anabolic-androgenic steroid (AAS), would likely mirror those applicable to other compounds in this category due to their similar mechanisms of action and potential side effects. While specific warnings for Neo-Poden are not detailed in the information provided, common health warnings associated with the use of AAS include:
- Liver Toxicity: Oral anabolic steroids, especially those that are 17α-alkylated (like Neo-Poden), can be hepatotoxic and may lead to liver damage or liver disease with long-term use or high dosages.
- Cardiovascular Risks: AAS can have negative effects on cholesterol levels (increasing LDL and decreasing HDL), blood pressure, and may contribute to cardiovascular disease, including heart attacks and strokes.
- Hormonal Imbalances: Use of AAS can disrupt the body’s natural hormone production, leading to conditions such as hypogonadism in men, menstrual irregularities in women, and potential infertility in both sexes.
- Psychiatric Effects: AAS use has been linked to mood swings, aggression (often referred to as “roid rage”), depression, and other changes in behavior.
- Masculinization in Women: Despite its low androgenicity, there is still a risk of virilization in female users, which can result in deepening of the voice, increased body hair, and changes in facial structure, some of which may be irreversible.
- Dependency and Withdrawal: There is a risk of becoming psychologically dependent on AAS, and abrupt cessation after prolonged use can lead to withdrawal symptoms.
- Interactions with Other Medications: AAS can interact with other medications, potentially altering their effects or increasing the risk of adverse reactions.
Raw Data
- Formula: C21H31NO2
- Molecular Weight: 329.47634 [g/mol]
- Effective Dose (Men): 15-40 mg/day
- Effective Dose (Women): 5-10 mg/day
- Half-Life: Unknown
- Detection Time: Unknown
- Anabolic/Androgenic Ratio: 155/22
- 17-alpha-Methylandrostan(3,2-c)isoxazol-17-beta-ol
- 17-Methyl-5alpha-androstano(3,2-c)isoxazol-17beta-ol
- 17-beta-Hydroxy-17-alpha-methylandrostano(3,2-c)isoxazole